Citadel Advisors’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$327K Sell
5,000
-27,100
-84% -$2.01M ﹤0.01% 10291
2025
Q4
$2.54M Sell
32,100
-40,825
-56% -$3.13M ﹤0.01% 5483
2025
Q3
$5.32M Buy
72,925
+9,025
+14% +$662K ﹤0.01% 4247
2025
Q2
$4.85M Sell
63,900
-127,975
-67% -$9.06M ﹤0.01% 4163
2025
Q1
$14.6M Buy
191,875
+49,600
+35% +$3.69M ﹤0.01% 2388
2024
Q4
$9.4M Sell
142,275
-162,300
-53% -$11.4M ﹤0.01% 3062
2024
Q3
$21.2M Buy
304,575
+166,650
+121% +$10M ﹤0.01% 1986
2024
Q2
$7.29M Buy
+137,925
New +$8.37M ﹤0.01% 3215

Other funds holding SOLV

Citadel Advisors's SOLV Position: Q1 2026 in Review

Citadel Advisors increased its Solventum (SOLV) stake by 431% in Q1 2026, buying an estimated $36.1M and bringing the position to 599,078 shares worth $39.1M. The position accounts for 0.01% of the portfolio, ranked #1585.

Citadel Advisors first reported a position in SOLV in Q1 2024 and has held it in 8 quarters since. The position peaked at $114M in Q3 2025. 878 funds tracked by Wall St. Rank hold SOLV as of Q1 2026.

  • Citadel Advisors held 599,078 shares of Solventum worth $39.1M as of Q1 2026.
  • Citadel Advisors bought 486,233 Solventum shares in Q1 2026, an estimated $36.1M.
  • Solventum made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1585 holding.
  • Citadel Advisors first reported a position in Solventum in Q1 2024 and has held it in 8 quarters since.
  • Citadel Advisors's Solventum position peaked at $114M in Q3 2025.
  • 878 funds tracked by Wall St. Rank held Solventum as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.